We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$64.1B
AUM Growth
-$17.5B
Cap. Flow
-$4.25B
Cap. Flow %
-6.62%
Top 10 Hldgs %
6.66%
Holding
4,541
New
702
Increased
1,343
Reduced
1,571
Closed
844

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$1.27B
2
ANDV
Andeavor
ANDV
+$1.11B
3
AET
Aetna Inc
AET
+$535M
4
MSFT icon
Microsoft
MSFT
+$350M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 13.69%
2 Technology 13.64%
3 Financials 12.49%
4 Consumer Discretionary 10.83%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLS icon
3676
Axcelis
ACLS
$3.83B
-43,975
Closed -$864K
ACWI icon
3677
iShares MSCI ACWI ETF
ACWI
$33.1B
-41,132
Closed -$3.05M
ACWX icon
3678
iShares MSCI ACWI ex US ETF
ACWX
$12.4B
-9,097
Closed -$434K
ADIL
3679
Adial Pharmaceuticals
ADIL
$13.9M
-27
Closed -$50K
ADNT icon
3680
CALL
Adient
ADNT
$1.45B
-100,000
Closed -$3.93M
AEM icon
3681
CALL
Agnico Eagle Mines
AEM
$109B
-56,000
Closed -$1.92M
AGCO icon
3682
PUT
AGCO
AGCO
$7.62B
-100,000
Closed -$6.08M
AGX icon
3683
Argan
AGX
$6.59B
-19,493
Closed -$838K
AHG
3684
Akso Health Group
AHG
$784M
-3,958
Closed -$94K
AIR icon
3685
AAR Corp
AIR
$5.34B
-156,622
Closed -$7.5M
AKO.B icon
3686
Embotelladora Andina Series B
AKO.B
$4.88B
-9,953
Closed -$228K
ALGN icon
3687
PUT
Align Technology
ALGN
$11.3B
-3,000
Closed -$1.17M
ALKS icon
3688
CALL
Alkermes
ALKS
$8.2B
-200,000
Closed -$8.49M
OSG
3689
Octave Specialty Group
OSG
$204M
-68,550
Closed -$1.4M
AMGN icon
3690
CALL
Amgen
AMGN
$240B
-250,000
Closed -$51.8M
AMGN icon
3691
PUT
Amgen
AMGN
$240B
-30,000
Closed -$6.22M
AMRX icon
3692
Amneal Pharmaceuticals
AMRX
$6.2B
-140,567
Closed -$3.12M
AMRC icon
3693
Ameresco
AMRC
$1.11B
-15,902
Closed -$217K
AMSF icon
3694
AMERISAFE
AMSF
$489M
-6,250
Closed -$387K
ANAB icon
3695
PUT
AnaptysBio
ANAB
$1.72B
-90,000
Closed -$8.98M
AN icon
3696
AutoNation
AN
$6.53B
-264,519
Closed -$11M
ANGO icon
3697
AngioDynamics
ANGO
$646M
-163,507
Closed -$3.56M
AOD
3698
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
-24,910
Closed -$219K
AOS icon
3699
CALL
A.O. Smith
AOS
$8.47B
-100,000
Closed -$5.34M
APVO icon
3700
Aptevo Therapeutics
APVO
$4.34M
0
-$70K

Similar funds

Israel Englander's Q4 2018 Portfolio in Review

As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.

  • Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
  • Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
  • Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
  • Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
  • Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
  • Israel Englander opened 702 new positions and closed 844 in Q4 2018.
  • Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.